Biocure Technology Inc.
CUREX
CNSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -97.07% | -12.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -97.07% | -12.58% | |||
| Operating Income | 97.07% | 12.58% | |||
| Income Before Tax | 55.10% | 16.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 55.10% | 16.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 55.10% | 16.48% | |||
| EBIT | 97.07% | 12.58% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 93.75% | 5.88% | |||
| Normalized Basic EPS | 90.00% | 9.09% | |||
| EPS Diluted | 93.75% | 5.88% | |||
| Normalized Diluted EPS | 90.00% | 9.09% | |||
| Average Basic Shares Outstanding | 800.00% | -12.12% | |||
| Average Diluted Shares Outstanding | 800.00% | -12.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||